10-Q – Page 198 – China Stock Advice

BSPM [Biostar Pharmaceuticals,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x September 30, 2010 For the quarterly period ended: Or For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, Maryland 20-8747899 (State or other jurisdiction oforporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with] [CERTIFICATION I, Deyin Chen, certify that: 1. I have reviewed this quarterly 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. ex32-1.htm 4 EX-32.1] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. ex32-2.htm 5 EX-32.2]

By info| 2016-02-07T16:41:31+00:00 November 12th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 10-Q, 2010-11-12, 2834, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 10-Q: FORM 10-Q (Mark One) x September 30, 2010

[FORM 10-Q (Mark One) x September 30, 2010 For the quarterly period ended: Or For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, Maryland 20-8747899 (State or other jurisdiction oforporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with] [CERTIFICATION I, Deyin Chen, certify that: 1. I have reviewed this quarterly 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. ex32-1.htm 4 EX-32.1] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. ex32-2.htm 5 EX-32.2]

By info| 2016-02-07T16:42:03+00:00 November 12th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 10-Q, 2010-11-12, 2834, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

NFEC [NF Energyvingrp] 10-Q: (Original Filing)

[FORM 10-Q x NF Energyvingrporation Delaware 02-0563302 (State or Other Jurisdiction oforporation or organization) (I.R.S. Employer Identification No.) Room 3105, Block C, 390 Qingnian Avenue, HePing District Shenyang, P. R. China 110003 (8624) 8563-1159 x Large accelerated filer Accelerated filer Non-accelerated filer x Smaller reportingmpany x - 1 -] [PREFERRED PROVIDER AND SERVICESREEMENTreement Party A Party B 2010 1 X RECITALS WHEREAS WHEREAS WHEREAS WHEREAS NOW, THEREFORE Preferred Provider Status. 1. 92; Each of the parties to thisreement will explore in good faith with the other for the potential development of new 0; Right of First Refusal] [Certifications I, Gang, Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of NF Energyvingrporation. 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [Certifications I, Li Hua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of NF Energyvingrporation. 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (1) The Report fullymplies with the requirements of Section 13(a) or 15(d) of the (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany for the nine months ended September 30, 2010.] [SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany for the nine months ended September 30, 2010. NF Energyvingrporation Principal Financial and Accounting Officer) ( v202027_ex32-2.htm]

By info| 2016-02-08T08:28:01+00:00 November 12th, 2010|Categories: Chinese Stocks, NFEC, SEC Original|Tags: 0001213660, 10-Q, 2010-11-12, 3490, MISCELLANEOUS FABRICATED METAL PRODUCTS, NFEC|0 Comments

TPI [TIANYIN PHARMACEUTICAL] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) For the quarterly period ended September 30, 2010 For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +0086-028-86154737 (Address, including zip code, and telephone number, Large Accelerated] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2)T he information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer & Chairman EX-32.1 4 ex32one.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong Chief Financial Officer, Chief Accounting Officer, Chief Business and Development Officer, Director EX-32.2 5]

By info| 2016-03-27T21:55:16+00:00 November 12th, 2010|Categories: Chinese Stocks, SEC Original, TPI|Tags: 0001362718, 10-Q, 2010-11-12, 2834, PHARMACEUTICAL PREPARATIONS, TPI|0 Comments

NFEC [NF Energyvingrp] 10-Q: FORM 10-Q x NF Energyvingrporation Delaware 02-0563302 (State

[FORM 10-Q x NF Energyvingrporation Delaware 02-0563302 (State or Other Jurisdiction oforporation or organization) (I.R.S. Employer Identification No.) Room 3105, Block C, 390 Qingnian Avenue, HePing District Shenyang, P. R. China 110003 (8624) 8563-1159 x Large accelerated filer Accelerated filer Non-accelerated filer x Smaller reportingmpany x - 1 -] [PREFERRED PROVIDER AND SERVICESREEMENTreement Party A Party B 2010 1 X RECITALS WHEREAS WHEREAS WHEREAS WHEREAS NOW, THEREFORE Preferred Provider Status. 1. 92; Each of the parties to thisreement will explore in good faith with the other for the potential development of new 0; Right of First Refusal] [Certifications I, Gang, Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of NF Energyvingrporation. 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [Certifications I, Li Hua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of NF Energyvingrporation. 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (1) The Report fullymplies with the requirements of Section 13(a) or 15(d) of the (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany for the nine months ended September 30, 2010.] [SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany for the nine months ended September 30, 2010. NF Energyvingrporation Principal Financial and Accounting Officer) ( v202027_ex32-2.htm]

By info| 2016-02-08T08:28:32+00:00 November 12th, 2010|Categories: Chinese Stocks, NFEC, Webplus ver|Tags: 0001213660, 10-Q, 2010-11-12, 3490, MISCELLANEOUS FABRICATED METAL PRODUCTS, NFEC|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x September 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including area code)] [Hainan Helpson Medical & Biotechnology Co., Ltd. Long-term Labor Contract Employer: Hainan Helpson Medical & Biotechnology Co., Ltd. (hereunder called Party A or Company) Zhilin Li Legal Representative/ authorised agent: Unit 8, D Area, Office Hall, Haikou Bonded Zone, Haikou Party A's address: 570216 Post Code: Zhilin Li (hereunder called Party B) Employee: Female Sex: 57 Age: Bachelor Education Level:] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 10, 2010 -------------------------------- President and Chief Executive Officer EX-32.1 5 cphi10qex321093010.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 10, 2010 --------------------- (principal financial officer and principal accounting officer) EX-32.2 6 cphi10qex322093010.htm]

By info| 2016-03-03T20:13:45+00:00 November 10th, 2010|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q, 2010-11-10, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x September 30, 2010

[FORM 10-Q (Mark One) x September 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including area code)] [Hainan Helpson Medical & Biotechnology Co., Ltd. Long-term Labor Contract Employer: Hainan Helpson Medical & Biotechnology Co., Ltd. (hereunder called Party A or Company) Zhilin Li Legal Representative/ authorised agent: Unit 8, D Area, Office Hall, Haikou Bonded Zone, Haikou Party A's address: 570216 Post Code: Zhilin Li (hereunder called Party B) Employee: Female Sex: 57 Age: Bachelor Education Level:] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 10, 2010 -------------------------------- President and Chief Executive Officer EX-32.1 5 cphi10qex321093010.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 10, 2010 --------------------- (principal financial officer and principal accounting officer) EX-32.2 6 cphi10qex322093010.htm]

By info| 2016-03-03T20:14:44+00:00 November 10th, 2010|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-Q, 2010-11-10, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x September 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Delaware 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China)] [Hainan Helpson Medical & Biotechnology Long-term Laborntract Employer:Hainan Helpson Medical & Biotechnology (hereunderlled Party A ormpany) Zhilin Li Legal Representative/ authorisedent: Unit 8, D Area, Office Hall, Haikou Bonded Zone, Haikou Party A'sdress: 570216 Postde: Zhilin Li (hereunderlled Party B)] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:November 10, 2010 -------------------------------- President and Chief Executive Officer cphi10qex321093010.htm 5 EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:November 10, 2010 --------------------- (principal financial officer and principal accounting officer) cphi10qex322093010.htm 6 EX-32.2]

By info| 2016-02-07T23:23:17+00:00 November 10th, 2010|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q, 2010-11-10, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x September 30, 2010

[FORM 10-Q (Mark One) x September 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Delaware 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China)] [Hainan Helpson Medical & Biotechnology Long-term Laborntract Employer:Hainan Helpson Medical & Biotechnology (hereunderlled Party A ormpany) Zhilin Li Legal Representative/ authorisedent: Unit 8, D Area, Office Hall, Haikou Bonded Zone, Haikou Party A'sdress: 570216 Postde: Zhilin Li (hereunderlled Party B)] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:November 10, 2010 -------------------------------- President and Chief Executive Officer cphi10qex321093010.htm 5 EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:November 10, 2010 --------------------- (principal financial officer and principal accounting officer) cphi10qex322093010.htm 6 EX-32.2]

By info| 2016-02-07T23:23:50+00:00 November 10th, 2010|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-Q, 2010-11-10, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

EGT [Entertainment Gaming Asia] 10-Q: (Original Filing)

[Table of Contents] [Section 302 Certification I, Clarence Chung, certify that: 1) I have reviewed this quarterly report on Form 10-Q of Entertainment Gaming Asia Inc.; 2) Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER Section 302 Certification I, Andy Tsui, certify that: 1) I have reviewed this quarterly report on Form 10-Q of Entertainment Gaming Asia Inc.; 2) Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. Dated: November 10, 2010 Clarence Chung President and Chief Executive Officer Dated: November 10, 2010 Andy Tsui Chief Accounting Officer]

By info| 2016-03-14T01:52:28+00:00 November 10th, 2010|Categories: Chinese Stocks, EGT, SEC Original|Tags: 0001004673, 10-Q, 2010-11-10, 3990, EGT, MISCELLANEOUS MANUFACTURING INDUSTRIES|0 Comments